REFERENCES
- Myers JE, Baker PN. Hypertensive diseases and eclampsia. Curr Opin Obstet Gynecol 2002; 14:119–125.
- Chen Q, Jones D, Stone P, Ching LM, Chamley L. C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation. Placenta 2009; 30:163–168.
- Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – A review. Placenta 2003; 24(Suppl.):21–27.
- Cleveland JL, Ihle JN. The Fas and the cytoplasmic apoptosis. Cell 1995; 81:479–483.
- Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449–1456.
- von Dadelszen P, Watson RW, Noorwali F, Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999; 181:408–414.
- Ishihara E, Matsuo H, Murakoshi H. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either pre-eclampsia or intrauterine growth retardation. Obst Gynecol. 1999; 181:408–414.
- ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. No. 33, January 2002 American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99:159–167.
- Pesce A, First M. Proteinurea – An integrated review. In: Cameron JS, et al. eds. Kidney Disease. Vol. 1, 1st ed., New York: Marcel Dekker, 1979:247–249.
- Arias F. Accuracy of the middle-cerebral-to-umbilical-artery resistance index ratio in the prediction of neonatal outcome in patients at high risk for fetal and neonatal complications. Am J Obstet Gynecol 1994; 171:1541–1545.
- Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17:781–828.
- Peter M, Scaffidi JM. The death receptors. Results Probl Cell Differ. 1999; 23:25–63.
- Protonotariou E, Rizos D, Malamitsi-Puchner A, Sarandakou A, Botsis D. Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life. In Vivo 2006; 20:901–905.
- Norwitz ER, Hsu CD, Repke JT. Acute complications of preeclampsia. Clin Obstet Gynecol 2002; 45:308–329.
- Wang W, Tzanidis A, Divjak M, Thomson NM, Stein-Oakley AN. Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12:1422–1433.
- Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189–1192.
- Hsu C, Hairab H, Serum Soluble BF. Fas levels in precclampsia. Obstet Gynecol 2002; 186:158–166.
- Sziller I, Hupuczi P, Normand N, Fas (TNFRSF6) gene polymorphism in pregnant women with hemolysis, elevated liver enzymes, and low platelets and in their neonates. Obstet Gynecol 2006; 107:582–587.
- Laskowska M, Laskowska K, Leszczynska-Gorzelak B, Oleszczuk J. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by pre-eclampsia with intrauterine growth retardation. Eur J Obstet Gynecol Reprod Biol 2005; 15:275–281.
- Aysun U, Gfluiliz G, Melek E, Ilhan T. Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings. Nephrology 2005; 10:311–316.
- Hoshimoto K, Hayashi M, Ohkura T. Plasma levels of soluble Fas during normal pregnancy. Gynecol Obstet Invest 2001; 51:96–98.
- Sato M, Knuma T. Fas-ligand system in the peripheral blood of patients with renal disease. Nephron 2000; 85:107–113.
- Cosson E, Bringuier F, Paries J, Ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance. Diabetes Metab 2005; 31:47–54.
- Baschat AA, Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003; 21:124–127.
- Jain M, Farooq T, Shukla RC. Doppler cerebroplacental ratio for the prediction of adverse perinatal outcome. Int J Gynaecol Obstet 2004; 86:384–385.
- To WW, Chan AM, Mok KM. Use of umbilical-cerebral Doppler ratios in predicting fetal growth restriction in near-term fetuses. Aust NZJ Obstet Gynaecol 2005; 45:130–136.
- Hoffman C, Galan HL. Assessing the “at-risk” fetus: Doppler ultrasound. Curr Opin Obstet Gynecol 2009; 21:161–166.